36028968|t|Lithium Cholesterol Sulfate: A Novel and Potential Drug for Treating Alzheimer's Disease and Autism Spectrum Disorder.
36028968|a|BACKGROUND AND OBJECTIVE: Recent studies have shown that lithium treatment can reduce symptoms of Alzheimer's disease (AD) and Autism Spectrum Disorder (ASD). However, the present lithium salts clinically available have serious short-term and long-term side effects which requires frequent monitoring of blood chemistry and plasma lithium levels so as to avoid toxicity. Consequently, there is a demand for a safer and more effective lithium formulation to treat these diseases. METHODS: Hence, we firstly synthesized lithium cholesterol sulfate (LiCS) and compared its pharmacological effects with that of lithium chloride (LiCl) and sodium cholesterol sulfate (NaCS) on markers of neurodegenerative disease in cell cultures. RESULTS: LiCS was more potent than LiCl in increasing inhibitory GSK3beta (Ser9) phosphorylation (pGSK3beta) in both CHO and SH-SY5Y cells. These agents dose-dependently increased pGSK3beta, starting at 10 microM for LiCS and 60microM for LiCl and maximally by approximately 100% at 60 microM for LiCS and 1.25 mM for LiCl, without altering total GSK3beta levels. In HEK293/tau cells, LiCS reduced tau (Thr231) phosphorylation (ptau) starting at 10 microM and maximally by 63% at 40 microM without altering total tau levels, but ptau levels were not altered by LiCl at any dose between 60 microM and 1.25 mM. In BV2 cells, LiCS and LiCl decreased LPS-induced TNFalpha levels, starting at 20 microM for LiCS and 5 mM for LiCl, and maximally by approximately 30% at 80 microM for LiCS and 20 mM for LiCl. NaCS at any dose between 5 and 90 microM did not alter pGSK3beta, ptau or LPS-induced TNFalpha. CONCLUSION: LiCS may become a new drug with good pharmacological potential for the treatment of neurodegenerative disorders such as AD and ASD by allowing lithium to more readily access intracellular pathological processes.
36028968	0	27	Lithium Cholesterol Sulfate	Chemical	-
36028968	69	88	Alzheimer's Disease	Disease	MESH:D000544
36028968	93	117	Autism Spectrum Disorder	Disease	MESH:D000067877
36028968	176	183	lithium	Chemical	MESH:D008094
36028968	217	236	Alzheimer's disease	Disease	MESH:D000544
36028968	238	240	AD	Disease	MESH:D000544
36028968	246	270	Autism Spectrum Disorder	Disease	MESH:D000067877
36028968	272	275	ASD	Disease	MESH:D000067877
36028968	299	306	lithium	Chemical	MESH:D008094
36028968	450	457	lithium	Chemical	MESH:D008094
36028968	480	488	toxicity	Disease	MESH:D064420
36028968	553	560	lithium	Chemical	MESH:D008094
36028968	637	664	lithium cholesterol sulfate	Chemical	-
36028968	666	670	LiCS	Chemical	-
36028968	726	742	lithium chloride	Chemical	MESH:D018021
36028968	744	748	LiCl	Chemical	MESH:D018021
36028968	754	780	sodium cholesterol sulfate	Chemical	-
36028968	782	786	NaCS	Chemical	-
36028968	802	827	neurodegenerative disease	Disease	MESH:D019636
36028968	855	859	LiCS	Chemical	-
36028968	881	885	LiCl	Chemical	MESH:D018021
36028968	911	919	GSK3beta	Gene	100760865
36028968	963	966	CHO	CellLine	CVCL:0213
36028968	971	978	SH-SY5Y	CellLine	CVCL:0019
36028968	1063	1067	LiCS	Chemical	-
36028968	1085	1089	LiCl	Chemical	MESH:D018021
36028968	1143	1147	LiCS	Chemical	-
36028968	1164	1168	LiCl	Chemical	MESH:D018021
36028968	1193	1201	GSK3beta	Gene	100760865
36028968	1213	1223	HEK293/tau	CellLine	CVCL:0045
36028968	1231	1235	LiCS	Chemical	-
36028968	1244	1247	tau	Gene	4137
36028968	1359	1362	tau	Gene	4137
36028968	1407	1411	LiCl	Chemical	MESH:D018021
36028968	1458	1461	BV2	CellLine	CVCL:0182
36028968	1469	1473	LiCS	Chemical	-
36028968	1478	1482	LiCl	Chemical	MESH:D018021
36028968	1493	1496	LPS	Chemical	MESH:D008070
36028968	1505	1513	TNFalpha	Gene	21926
36028968	1548	1552	LiCS	Chemical	-
36028968	1566	1570	LiCl	Chemical	MESH:D018021
36028968	1624	1628	LiCS	Chemical	-
36028968	1643	1647	LiCl	Chemical	MESH:D018021
36028968	1649	1653	NaCS	Chemical	-
36028968	1723	1726	LPS	Chemical	MESH:D008070
36028968	1735	1743	TNFalpha	Gene	7124
36028968	1757	1761	LiCS	Chemical	-
36028968	1841	1868	neurodegenerative disorders	Disease	MESH:D019636
36028968	1877	1879	AD	Disease	MESH:D000544
36028968	1884	1887	ASD	Disease	MESH:D000067877
36028968	1900	1907	lithium	Chemical	MESH:D008094
36028968	Negative_Correlation	MESH:D008094	MESH:D000067877
36028968	Negative_Correlation	MESH:D008070	MESH:D018021
36028968	Negative_Correlation	MESH:D008094	MESH:D000544
36028968	Positive_Correlation	MESH:D008070	21926
36028968	Negative_Correlation	MESH:D018021	100760865
36028968	Negative_Correlation	MESH:D018021	7124
36028968	Negative_Correlation	MESH:D018021	21926

